JP2003524636A - プリン性受容体アゴニストによる胃腸管の処置方法 - Google Patents
プリン性受容体アゴニストによる胃腸管の処置方法Info
- Publication number
- JP2003524636A JP2003524636A JP2001546630A JP2001546630A JP2003524636A JP 2003524636 A JP2003524636 A JP 2003524636A JP 2001546630 A JP2001546630 A JP 2001546630A JP 2001546630 A JP2001546630 A JP 2001546630A JP 2003524636 A JP2003524636 A JP 2003524636A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- substituted
- amino
- secretion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17171099P | 1999-12-22 | 1999-12-22 | |
US60/171,710 | 1999-12-22 | ||
PCT/US2000/035439 WO2001045691A2 (en) | 1999-12-22 | 2000-12-22 | Method of treating gastrointestinal tract disease with purinergic receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003524636A true JP2003524636A (ja) | 2003-08-19 |
Family
ID=22624842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001546630A Pending JP2003524636A (ja) | 1999-12-22 | 2000-12-22 | プリン性受容体アゴニストによる胃腸管の処置方法 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1261323A2 (ko) |
JP (1) | JP2003524636A (ko) |
KR (1) | KR20020069218A (ko) |
CN (1) | CN1413113A (ko) |
AU (1) | AU2603101A (ko) |
BR (1) | BR0016021A (ko) |
CA (1) | CA2395108A1 (ko) |
MX (1) | MXPA02005161A (ko) |
WO (1) | WO2001045691A2 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006001492A1 (ja) * | 2004-06-28 | 2006-01-05 | Ajinomoto Co., Inc. | 栄養組成物および消化管機能低下予防・改善用組成物 |
WO2006030980A1 (ja) * | 2004-09-17 | 2006-03-23 | Ajinomoto Co., Inc. | 機能性消化管障害予防・改善剤及び食品 |
JP2009173564A (ja) * | 2008-01-23 | 2009-08-06 | Yamasa Shoyu Co Ltd | 唾液分泌促進剤 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7629329B2 (en) | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
WO2003039473A2 (en) * | 2001-11-06 | 2003-05-15 | Inspire Pharmaceuticals, Inc. | Method for treating or preventing inflammatory diseases |
US7049303B2 (en) * | 2001-11-07 | 2006-05-23 | Medical Research Council | Inhibition of viruses |
TWI263505B (en) * | 2001-11-19 | 2006-10-11 | Sucampo Ag | Pharmaceutical composition comprising a C1C-2 channel opener |
EP1348466A3 (en) | 2002-02-01 | 2003-10-29 | Inspire Pharmaceuticals, Inc. | Method for treating pain with adenosine-tetraphosphates |
US6683060B2 (en) * | 2002-02-25 | 2004-01-27 | Advanced Gene Technology Corp. | Matrix metalloproteinase and tumor necrosis factor inhibitors |
AU2003217863B9 (en) | 2002-02-28 | 2009-10-29 | Biota Scientific Management Pty Ltd | Nucleotide mimics and their prodrugs |
GB0312844D0 (en) * | 2003-06-04 | 2003-07-09 | Paradigm Therapeutics Ltd | Use of compounds in medicine |
GB201320959D0 (en) * | 2013-11-27 | 2014-01-08 | Globalacorn Ltd | Compositions |
GB201320962D0 (en) * | 2013-11-27 | 2014-01-08 | Globalacorn Ltd | Compositions |
EP3962493A2 (en) | 2019-05-03 | 2022-03-09 | Flagship Pioneering Innovations V, Inc. | Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7395094A (en) * | 1993-10-15 | 1995-05-04 | Wisconsin Alumni Research Foundation | Substituted purine nucleoside analogs and method for treating endotoxin shock |
US5837861A (en) * | 1997-02-10 | 1998-11-17 | Inspire Pharmaceuticals, Inc. | Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
CN1262556C (zh) * | 1997-02-06 | 2006-07-05 | 印斯拜尔药品股份有限公司 | 特定的二核苷酸和它们作为粘膜纤毛清除和纤毛颤动频率调节剂的应用 |
AU3612600A (en) * | 1999-02-26 | 2000-09-14 | Inspire Pharmaceuticals, Inc. | Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
-
2000
- 2000-12-22 MX MXPA02005161A patent/MXPA02005161A/es unknown
- 2000-12-22 CA CA002395108A patent/CA2395108A1/en not_active Abandoned
- 2000-12-22 WO PCT/US2000/035439 patent/WO2001045691A2/en not_active Application Discontinuation
- 2000-12-22 JP JP2001546630A patent/JP2003524636A/ja active Pending
- 2000-12-22 BR BR0016021-0A patent/BR0016021A/pt not_active Application Discontinuation
- 2000-12-22 CN CN00817607A patent/CN1413113A/zh active Pending
- 2000-12-22 AU AU26031/01A patent/AU2603101A/en not_active Abandoned
- 2000-12-22 KR KR1020027007963A patent/KR20020069218A/ko not_active Application Discontinuation
- 2000-12-22 EP EP00989533A patent/EP1261323A2/en not_active Withdrawn
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006001492A1 (ja) * | 2004-06-28 | 2006-01-05 | Ajinomoto Co., Inc. | 栄養組成物および消化管機能低下予防・改善用組成物 |
JPWO2006001492A1 (ja) * | 2004-06-28 | 2008-04-17 | 味の素株式会社 | 栄養組成物および消化管機能低下予防・改善用組成物 |
US7993668B2 (en) | 2004-06-28 | 2011-08-09 | Ajinomoto Co., Inc. | Nutrient composition and composition for prevention/mitigation of digestive tract depression |
WO2006030980A1 (ja) * | 2004-09-17 | 2006-03-23 | Ajinomoto Co., Inc. | 機能性消化管障害予防・改善剤及び食品 |
JP2009173564A (ja) * | 2008-01-23 | 2009-08-06 | Yamasa Shoyu Co Ltd | 唾液分泌促進剤 |
Also Published As
Publication number | Publication date |
---|---|
AU2603101A (en) | 2001-07-03 |
EP1261323A2 (en) | 2002-12-04 |
BR0016021A (pt) | 2003-07-15 |
CN1413113A (zh) | 2003-04-23 |
MXPA02005161A (es) | 2002-12-09 |
CA2395108A1 (en) | 2001-06-28 |
WO2001045691A3 (en) | 2002-04-18 |
WO2001045691A2 (en) | 2001-06-28 |
KR20020069218A (ko) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6624150B2 (en) | Method of treating gastrointestinal tract disease with purinergic receptor agonists | |
JP4633927B2 (ja) | 治療用ジヌクレオチドおよび誘導体 | |
JP2003524636A (ja) | プリン性受容体アゴニストによる胃腸管の処置方法 | |
JP3652707B2 (ja) | プリン受容体アゴニストによるドライアイ疾患の治療法 | |
CA2352262A1 (en) | Method of promoting cervical and vaginal secretions | |
JP4531867B2 (ja) | 一定のジヌクレオチドおよび粘膜繊毛クリアランスおよび繊毛運動頻度のモジュレーターとしてのそれらの使用 | |
KR20010114214A (ko) | 우리딘, 아데닌 및 시티딘 디포스페이트 및 그의 유사체에의한 점막수화 촉진방법 | |
US6864243B1 (en) | Method for treating retinal degeneration with purinergic receptor agonists | |
Zhao et al. | Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells | |
JP2006515306A (ja) | Pseudomonas細菌感染の処置のためのオリゴ糖およびその結合体 | |
US6555675B2 (en) | Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists | |
US7256183B2 (en) | Method for treating or preventing inflammatory diseases | |
US6673779B2 (en) | Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues | |
WO2019143192A1 (ko) | 듀니온을 유효성분으로 포함하는 탈모의 예방 또는 개선용 조성물 | |
AU2002352536A1 (en) | Method for treating or preventing inflammatory diseases | |
MXPA99007235A (en) | Method of treating dry eye disease with purinergic receptor agonists |